Clene Inc. CLNN
- CNM-Au8 — Amyotrophic Lateral Sclerosis NDA Submitted
- CNM-Au8 — Multiple Sclerosis Phase 2
- CNM-Au8 — Parkinson's Disease Phase 2
Home › Targets › mitochondrial dysfunction
mitochondrial dysfunction (2 companies · 4 programs)
Companies with an active program directed at mitochondrial dysfunction.
Amylyx Pharmaceuticals, Inc. AMLX
- sodium phenylbutyrate and taurursodiol — Wolfram Syndrome Phase 2